LRN vs MRNA · P/E 22, rev $2.52B vs rev $145.0M
Stride Inc (LRN) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Stride Inc (LRN) is a education & training services company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported LRN revenue for 2026-06-30 was $2.52B. Net income was $338.2M. Revenue was up 4.7% from 2025-06-30 to 2026-06-30. LRN currently screens at market cap $6.03B and trailing P/E 21.7.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
LRN currently screens at market cap $6.03B and trailing P/E 21.7. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the LRN and MRNA stock pages for the full models.
Not investment advice.